Predicting late rectal complications following prostate conformal radiotherapy using biologically effective doses and normalized dose-surface histograms

British Journal of Radiology

Volumn 70, Issue MAY, 1997, Pages 517-526

  MacKay, R I ^a   Hendry, J H ^a   Moore, C J ^a   Williams, P C ^a   Read, G ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; FRACTIONATION; HISTOGRAM; PREDICTION; PROSTATE CANCER; RADIATION DOSE; RECTUM DISEASE; TOXICITY;

EID: 0030905738     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.70.833.9227235     Document Type: Article

References (42)

1. Corn BW, Hanks GE, Schultheiss TE, et al. Conformal treatment of prostate cancer with improved targeting: superior prostate specific antigen response compared to standard treatment. Int J Radiat Oncol Biol Phys 1995;32:325-30.
2. Hanks GE, Hanlon A, Schultheiss T, et al. Early prostate cancer: the national results of radiation treatment from the Patterns of Care and Radiation Therapy Oncology Group studies with prospects for improvement and adjuvant androgen deprivation. J Urol 1994; 152:1775-80.
3. Liebel SA, Zelefsky MJ, Kutcher GJ, et al. Three dimensional conformal radiation therapy in localised carcinoma of the prostate: interim report of a phase 1 dose escalation study. J Urol 1994; 152:1792-8.
4. Mageras GS, Fuks Z, O'Brien J, et al. Initial clinical experience with computer controlled conformal therapy of the prostate using a 50 MeV medical micro-Iron. Int J Radiat Oncol Biol Phys 1994;15:971-8.
5. Perez CA, Purdy JA, Harms W, et al. Three dimensional treatment planning and conformal therapy: Preliminary evaluation. Radiother Oncol 1995; 36:32-43.
6. Ray GR, Cassady JR, Bagshaw MA. Definitive radiation therapy of carcinoma of the prostate. Radiology 1973;106:407-18.
7. Sandier HM, Perez Tamayo C, Ten Haken RK, Lichetr AS. Dose escalation for stage C (T3) prostate cancer: Minimal rectal toxicity observed using conformal therapy. Radiother. Oncol. 1992;23:53-4.
8. Lu Y, Song PY, Shi-Dong L, Speibring DR, et al. A method of analyzing rectal surface area irradiated and rectal complications in prostate conformal radiotherapy. Int J Radiat Oncol Biol Phys 1995;33:1121-5.
9. Oldham M, Webb S. The optimization and inherent limitations of 3D conformal radiotherapy treatment plans of the prostate. Br J Radiol 1995:68:882-93.
10. Oldham MN, Neal AJ, Webb SA. A comparison of conventional forward planning with inverse planning for 3D conformal therapy of the prostate. Radiother Oncol 1995:35:248-62.
11. Lyman JT. Complication probability - as assessed from dose volume histograms. Radiat Res 1985;104:513-19.
12. Niemierko A, Goitein M. Calculation of normal tissue complication probability and dose-volume histogram reduction schemes for tissues with a critical element architecture. Radiother Oncol 1991;20:166-76.
13. Kutcher JG, Burman C, Brewster L, et al. Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations. Int J Radiat Oncol Biol Phys 1991;21:137-46.
14. Jackson A, Kutcher GJ, Yorke ED. Probability of radiation-induced complications for normal tissues with parallel architecture subject to non-uniform irradiation. Med Phys 1993;20:613-25.
15. Niemierko A, Goitein M. Modelling of normal tissue response to radiation: the critical volume model. Int J Radiat Oncol Biol Phys 1993;25:131-45.
16. Kallman P, Ågren A, Brahme A. Tumour and normal tissue responses to fractionated non-uniform dose delivery. Int J Radiat Biol 1992;62:249-62.
17. Thames HD, Hendry JH. Fractionation in Radiotherapy. London: Taylor & Francis, 1987: 53-99.
18. Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989;62:679-94.
19. Yaes JR. The biological effect of inhomogeneous dose distributions in fractionated radiotherapy. Int J Radiat Oncol Biol Phys 1990;19:203-7.
20. Lee SP, Leu MY, Smathers JB, et al. Biological effective dose distribution based on the linear quadratic model and its clinical relevance. Int J Radiat Oncol Biol Phys 1995;33:375-89.
21. Lebesque JV, Keus RB. The simultaneous boost technique: the concept of relative normalised total dose. Radiother Oncol 1991;22:45-55.
22. Lu Y, Li S, Speibring D, et al. Dose-surface-histograms as a treatment planning tool for prostate conformal therapy. Med Phys 1994;22:279-84.
23. Hounsell AR, Wilkinson JM. Tissue standard ratios for irregularly shaped radiotherapy fields. Br J Radiol 1990;63:629-34.
24. Hounsell AR, Wilkinson JM. Dose calculations in multileaf collimator fields. In: Hounsell AR, Wilkinson JM, Williams PC, editors. Proceedings of the XIth International Conference on the use of Computers in Radiation Therapy. Manchester: North Western Medical Physics Department, Christie Hospital NHS Trust, 1994.
25. Withers HR, Taylor JMG, Maciejewski B. Treatment volume and tissue tolerance. Int J Radiat Oncol Biol Phys 1988;14:751-59.
26. Ågren A, Brahme A, Turesson I. Optimisation of uncomplicated control for head and neck tumors. Int J Radiat Oncol Biol Phys 1990;19:1077-85.
27. Södertröm S, Brahme A. Optimisation of the dose delivery in a few field techniques using radiobiological objective functions. Med Phys 1993;20:1201-10.
28. Södertröm S, Gustafsson A, Brahme A. Few-field radiation therapy optimization in the phase space of complication-free tumor control. Int J Imag Sys Tech 1995;6:91-103.
29. Södertröm S, Brahme A. Which is the most suitable number of photon beam portals in coplanar radiation therapy? Int J Radiat Oncol Biol Phys 1995;33:151-9.
30. Gagliardi G, Lax I, Ottolenghi A, Rutqvist LE. Long-term cardiac mortality after radiotherapy of breast cancer-application of relative seriality model. Br J Radiol 1996;69:839-45.
31. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21:109-22.
32. Lebesque JV, Bruce AM, Kroes AP, et al. Variation in volumes, dose-volume histograms, and estimated normal tissue complication probabilities of rectum and bladder during conformal radiotherapy of T3 prostate cancer. Int J Radiat Oncol Biol Phys 1995;33:1109-19.
33. Schultheiss TE, Orton CG, Peck RA. Models in radiotherapy: Volume effects. Med Phys 1983;10:410-15.
34. Dubray BM, Thames HD. Chronic radiation damage in the rat rectum: an analysis of the influences of fractionation, time and volume. Radiother Oncol 1994;33:41-7.
35. Hounsell AR, Sharrock PJ, Moore CJ, et al. Computer-assisted generation of multileaf collimator settings for conformation therapy. Br J Radiol 1991;65:321-6.
36. Pointon RCS. Genitourinary tract. In: Radiotherapy Of Malignant Disease. London: Springer Verlag, 1991:309-28.
37. Neal AJ, Oldham M, Dearnaley DP. Comparison of treatment techniques for conformal radiotherapy of the prostate using dose-volume histograms and normal tissue complication probabilities. Radiother Oncol 1995;37:29-34.
38. Ling CF, Burman C, Chui CS, et al. Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation. Int J Radiat Oncol Biol Phys 1996;35:721-30.
39. West CML. Intrinsic radiosensitivity as a predictor of patient response to radiotherapy. Br J Radiol 1995;68:827-37.
40. Trott KR, Tamou S, Sassy T, Kiszel Z. The effect of irradiated volume on the chronic radiation damage of the rat large bowel. Strahlenther Onkol 1995;171:326-31.
41. Trott KR. Chronic damage after radiation therapy: challenge to radiation biology. Int J Radiat Oncol Biol Phys 1984;10:907-13.
42. Trott KR, Herrman T. Radiation effects on abdominal organs, radiopathology of organs and tissues. In: Scherer E, Streffer Ch, Trott KR, editors. Medical Radiology. Berlin: Springer-Verlag, 1991:318-28.